SSTR4
Basic information
Region (hg38): 20:23035312-23039237
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SSTR4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 28 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 1 | 4 |
Variants in SSTR4
This is a list of pathogenic ClinVar variants found in the SSTR4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-23035533-C-A | not specified | Uncertain significance (Aug 02, 2023) | ||
20-23035534-G-C | Benign (Aug 16, 2018) | |||
20-23035565-G-T | not specified | Uncertain significance (Feb 28, 2024) | ||
20-23035568-C-G | not specified | Uncertain significance (Nov 07, 2022) | ||
20-23035583-G-C | not specified | Uncertain significance (Mar 07, 2023) | ||
20-23035584-A-T | not specified | Uncertain significance (Mar 07, 2023) | ||
20-23035616-G-C | not specified | Uncertain significance (Dec 22, 2023) | ||
20-23035619-G-C | not specified | Uncertain significance (Aug 17, 2022) | ||
20-23035622-A-G | not specified | Uncertain significance (Oct 06, 2021) | ||
20-23035625-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
20-23035811-C-A | not specified | Uncertain significance (Apr 23, 2024) | ||
20-23035825-C-A | not specified | Uncertain significance (Dec 07, 2021) | ||
20-23035857-T-A | not specified | Uncertain significance (Feb 12, 2024) | ||
20-23035947-C-T | not specified | Uncertain significance (Apr 20, 2023) | ||
20-23036060-G-T | not specified | Uncertain significance (Oct 05, 2023) | ||
20-23036106-C-T | not specified | Uncertain significance (Oct 05, 2022) | ||
20-23036113-C-A | Benign (Jun 18, 2018) | |||
20-23036120-G-T | not specified | Uncertain significance (Mar 02, 2023) | ||
20-23036126-A-G | not specified | Uncertain significance (Sep 22, 2022) | ||
20-23036175-A-G | not specified | Uncertain significance (Apr 01, 2024) | ||
20-23036182-C-T | Benign (Jul 15, 2018) | |||
20-23036202-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
20-23036232-G-A | not specified | Uncertain significance (May 09, 2023) | ||
20-23036241-C-G | not specified | Uncertain significance (Jul 12, 2022) | ||
20-23036242-G-A | Benign (Jun 14, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SSTR4 | protein_coding | protein_coding | ENST00000255008 | 1 | 1258 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.70e-13 | 0.00174 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.231 | 279 | 268 | 1.04 | 0.0000189 | 2422 |
Missense in Polyphen | 101 | 101.93 | 0.99086 | 1045 | ||
Synonymous | 1.55 | 110 | 133 | 0.829 | 0.0000103 | 889 |
Loss of Function | -2.23 | 15 | 8.14 | 1.84 | 4.36e-7 | 74 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for somatostatin-14. The activity of this receptor is mediated by G proteins which inhibits adenylyl cyclase. It is functionally coupled not only to inhibition of adenylate cyclase, but also to activation of both arachidonate release and mitogen-activated protein (MAP) kinase cascade. Mediates antiproliferative action of somatostatin in tumor cells.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);Pantoprazole Action Pathway;Rabeprazole Action Pathway;Esomeprazole Action Pathway;Omeprazole Action Pathway;Lansoprazole Action Pathway;Gastric Acid Production;Nizatidine Action Pathway;Cimetidine Action Pathway;Famotidine Action Pathway;Ranitidine Action Pathway;Betazole Action Pathway;Roxatidine acetate Action Pathway;Metiamide Action Pathway;Pirenzepine Action Pathway;Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.643
- rvis_EVS
- -0.33
- rvis_percentile_EVS
- 30.7
Haploinsufficiency Scores
- pHI
- 0.0873
- hipred
- N
- hipred_score
- 0.312
- ghis
- 0.408
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.557
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sstr4
- Phenotype
- homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); immune system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;neuropeptide signaling pathway;negative regulation of cell population proliferation;cell migration;forebrain development;somatostatin signaling pathway;positive regulation of ERK1 and ERK2 cascade;cellular response to glucocorticoid stimulus;positive regulation of arachidonic acid secretion;negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway
- Cellular component
- cytoplasm;plasma membrane;integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;somatostatin receptor activity;peptide binding;neuropeptide binding